(Press-News.org) TEMPE, Ariz. — The Physicians Committee for Responsible Medicine filed a complaint with the National Institutes of Health’s Office of Laboratory Animal Welfare today, May 19, 2025, asking for an investigation of Arizona State University’s use of animals to study the effects of dietary supplements on adults with Down syndrome.
“Arizona State University cannot justify its use of mice to study a common nutrient that could be easily and ethically studied in consenting human volunteers,” the complaint says. “These uses of animals run afoul of the Public Health Service Policy that replacement of animals be considered. Using animals to research human nutrition is a step backward in terms of scientific relevance. The use of animals in this experiment demonstrates both a lack of scientific merit and research misconduct.”
A March 24, 2025, letter from the Physicians Committee brought the issue to the attention of Arizona State officials.
The study, which received financial support from the NIH, purported to investigate the effects of dietary choline supplementation on biological and cognitive outcomes in Down syndrome.
For the experiment, 67 mice were given choline over a 10-month period. The animals were then studied using often-invasive and painful procedures, including brain implants. At the study’s conclusion, all the mice were killed, and their brains and portions of their liver lobes were collected.
”This experiment should never have been approved. Choline is an essential nutrient that has already been safely studied in humans, including individuals with Down syndrome,” said Physicians Committee Science Policy Program Manager Janine McCarthy. “Arizona State University’s decision to use mice—despite the known translational failures of using animals in research—is not only scientifically unjustifiable, it disregards federal policies that promote the use of alternatives when available.”
Further, the information gathered from using mice cannot reflect the complex genetics of Down syndrome, McCarthy said.
Federal guidelines state that the “use of laboratory animals for biomedical research, testing and education is guided by the principles of the Three Rs” and explicitly endorses “consideration of alternatives … to reduce or replace the use of animals” and “use of appropriate species.” The principal investigator did not meet this requirement because there is no rationale for animal use given the abundance of clinical research examining these interventions, the Physicians Committee’s complaint says.
Decades of studies using mice have failed to yield effective treatments for people with Down syndrome. Continuing to use animals delays progress and diverts resources from research that could truly benefit this population. The Physicians Committee requests that the NIH investigate the matter and order corrective action and appropriate penalties.
Over 85% of more than 2,000 respondents polled in September 2024 in a Physicians Committee/Morning Consult survey agreed that animal-based research should be phased out in support of superior methods that do not use animals.
In contrast to animal experimentation, modern and versatile human-relevant methods, such as tissue chips, organoids, computational modeling, and high-throughput screening, have proven effective in drug development and disease modeling. They are also more representative of human beings, and of their biological variability, and more accurately model the complex, specific, genetic, and biological basis of human diseases and conditions.
Media Contact
Kim Kilbride
202-717-8665
kkilbride@pcrm.org
Founded in 1985, the Physicians Committee for Responsible Medicine is a nonprofit organization that promotes preventive medicine, conducts clinical research, and encourages higher standards for ethics and effectiveness in education and research.
END
Doctors group asks National Institutes of Health to investigate Arizona State University for research misconduct
2025-05-20
ELSE PRESS RELEASES FROM THIS DATE:
St. Jude scientist Charles Mullighan elected to the Royal Society of London
2025-05-20
St. Jude Children’s Research Hospital leukemia researcher Charles G. Mullighan, MBBS (Hons), MSc, MD, senior deputy director of the St. Jude Comprehensive Cancer Center, has been elected as a Fellow of the Royal Society of London, the oldest scientific academy in continuous existence.
Mullighan was selected to join the Royal Society for his trailblazing contributions to genomic research, which have advanced the understanding, diagnosis and treatment of acute leukemia, notably childhood acute lymphoblastic leukemia ...
1.5°C Paris Climate Agreement target too high for polar ice sheets and sea level rise
2025-05-20
Efforts to limit the global temperature increase to 1.5°C under the Paris Climate Agreement may not go far enough to save the world’s ice sheets, according to a new study.
Research led by Durham University, UK, suggests the target should instead be closer to 1°C to avoid significant losses from the polar ice sheets and prevent a further acceleration in sea level rise.
The team reviewed a wealth of evidence to examine the effect that the 1.5°C target would have on the ice sheets in Greenland and Antarctica, which together store enough ice to raise global sea levels by almost 65 metres.
The mass of ice lost from these ice ...
Scientists discover potential new targets for Alzheimer’s drugs
2025-05-20
CAMBRIDGE, MA -- By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer’s disease.
The study revealed genes and cellular pathways that haven’t been linked to Alzheimer’s before, including one involved in DNA repair. Identifying new drug targets is critical because many of the Alzheimer’s drugs that have been developed to this point haven’t been as successful as hoped.
Working with researchers at Harvard Medical School, the team used data from humans and fruit flies to identify cellular pathways linked to neurodegeneration. ...
Scientists develop new treatment with potential to tackle commonest form of childhood cancer
2025-05-20
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.
Although the research has so far only been conducted in cell lines and mice, the team is seeking funding to begin clinical trials in patients shortly.
More than 500 people a year in the UK are diagnosed with B-ALL, many of whom are children, where it makes up 40% of all ...
Technique rapidly measures cells’ density, reflecting health and developmental state
2025-05-20
CAMBRIDGE, MA -- Measuring the density of a cell can reveal a great deal about the cell’s state. As cells proliferate, differentiate, or undergo cell death, they may gain or lose water and other molecules, which is revealed by changes in density.
Tracking these tiny changes in cells’ physical state is difficult to do at a large scale, especially with single-cell resolution, but a team of MIT researchers has now found a way to measure cell density quickly and accurately — measuring up to 30,000 cells in a single hour.
The researchers also showed that density ...
Mask users can now breathe easy on two counts
2025-05-20
Tokyo, Japan—The COVID-19 pandemic increased public awareness of the importance of mask use for personal protection. However, when the mesh size of mask fabrics is small enough to capture viruses, which are usually around one hundred nanometers in size, the fabric typically also restricts air flow, resulting in user discomfort. But now, researchers from Japan have found a way to avoid this.
In a study published this month in Materials Advances, researchers from the Institute of Industrial Science, The University of Tokyo have overcome this bottleneck and developed a filter capable of capturing nanoparticles such ...
Aging reduces CAR-T cell effectiveness by impairing metabolism, study shows
2025-05-20
As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing immune cells. In a new study published in Nature Cancer, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG) and the Ecole Polytechnique Fédérale de Lausanne (EPFL), show that this age-related immune decline has a measurable impact on CAR-T cell therapy, one of the most advanced forms of cancer immunotherapy.
CAR-T ...
Why are patients with mitochondrial disease more susceptible to infections? New JAX study finds the answer
2025-05-20
Patients with rare mitochondrial diseases already face a host of serious health issues, from muscle weakness to neurological problems and heart conditions. But one of their most life-threatening challenges has remained a mystery—why are they so vulnerable to severe infections?
Now, scientists at The Jackson Laboratory (JAX) may have finally pinpointed why. Their new study, published in Nature Communications, shows that damaged mitochondria put the immune system in a constant state of alert, leading to dangerous overreactions when patients encounter bacteria. This excessive immune ...
National Heart Centre Singapore implements cutting-edge artificial intelligence in nationwide project for rapid coronary artery disease prediction
2025-05-20
SENSE, a nationwide artificial intelligence (AI) initiative to interpret cardiac imaging scans in minutes, aiding early detection and prediction of coronary artery disease.
NHCS CVS.AI Research Laboratory, a new purpose-built and dedicated facility with enhanced infrastructure to advance and drive novel AI technology in cardiac imaging.
Singapore, 20 May 2025 – The National Heart Centre Singapore (NHCS) announces a major advancement in cardiac care research with the implementation of SENSE (Singapore hEart lesioN analySEr), a nationwide AI initiative that reduces the time taken to analyse cardiac scans, from hours to minutes. This breakthrough system will transform the ...
How molecules can ‘remember’ and contribute to memory and learning
2025-05-20
Researchers have discovered how an ion channel in the brain’s neurons has a kind of ‘molecular memory’, which contributes to the formation and preservation of lifelong memories. The researchers have identified a specific part of the ion channel at which new drugs for certain genetic diseases could be targeted. The study, led from Linköping University in Sweden, has been published in Nature Communications.
One of the brain’s superpowers is its ability to learn from past experiences and form memories. These vital processes depend on the reshaping of connections between neurons in the brain. ...